Effect of lipopeptides and iontophoresis on aciclovir skin delivery

Journal of Pharmacy and Pharmacology

Volumn 62, Issue 6, 2010, Pages 702-708

  Nicoli, Sara ^a   Eeman, Marc ^b   Deleu, Magali ^b   Bresciani, Eleonora ^a   Padula, Cristina ^a   Santi, Patrizia ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Biosurfactant; Epidermis; Iontophoresis; Lipopeptide; Transdermal penetration

Indexed keywords

ACICLOVIR; FENGYCIN; LIPOPEPTIDE; SURFACTIN; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; CYCLOPEPTIDE; EXCIPIENT; SURFACTANT; SURFACTIN PEPTIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TRANSPORT; IONTOPHORESIS; NONHUMAN; STRATUM CORNEUM; SWINE; ANIMAL; CHEMISTRY; DRUG POTENTIATION; METABOLISM; PERMEABILITY; SKIN; SKIN ABSORPTION;

ACYCLOVIR; ANIMALS; ANTIVIRAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG SYNERGISM; EXCIPIENTS; IONTOPHORESIS; LIPOPEPTIDES; PEPTIDES, CYCLIC; PERMEABILITY; SKIN; SKIN ABSORPTION; SURFACE-ACTIVE AGENTS; SWINE;

EID: 77953600852     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.62.06.0006     Document Type: Article

References (30)

1. Rodrigues L et al. Biosurfactants: potential applications in medicine. J Antimicrob Chemother 2006 57: 609 618.
2. Deleu M et al. Interfacial and emulsifying properties of lipopeptides from Bacillus subtilis. Colloid Surface Physicochem Eng Aspect 1999 152: 3 10.
3. Deleu M et al. Fengycin interaction with lipid monolayers at the air-aqueous interface: implications for the effect of fengycin on biological membranes. J Colloid Interface Sci 2005 283: 358 365.
4. Deleu M et al. Effect of fengycin, a lipopeptide produced by Bacillus subtilis, on model biomembranes. Biophys J 2008 94: 2667 2679.
5. Eeman M et al. Penetration of surfactin into phospholipid monolayers: nanoscale interfacial organization. Langmuir 2006 22: 11337 11345.
6. Seydlová G, Svobodová J. Review of surfactin chemical properties and the potential biomedical applications. Cent Eur J Med 2008 3: 123 133.
7. Eeman M et al. Nanoscale properties of mixed fengycin/ceramide monolayers explored using atomic force microscopy. Langmuir 2005 21: 2505 2511.
8. Eeman M et al. Effect of cholesterol and fatty acids on the molecular interactions of fengycin with stratum corneum mimicking lipid monolayers. Langmuir 2009 25: 3029 3039.
9. Lin P et al. Changing paradigms in dermatology: antivirals in dermatology. Clin Dermatol 2003 21: 426 446.
10. O'Brien JJ, Campoli-Richards DM. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1989 37: 233 309.
11. Guy RH et al. Iontophoresis: electrorepulsion and electroosmosis. J Control Release 2000 64: 129 132.
12. Dick IP, Scott RC. Pig ear skin as an in-vitro model for human skin permeability. J Pharm Pharmacol 1992 44: 640 645.
13. Sekkat N et al. Biophysical study of porcine ear skin in vitro and its comparison to human skin in vivo. J Pharm Sci 2002 91: 2376 2381.
14. Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: qualitative and quantitative observations-an overview. Skin Pharmacol Appl Skin Physiol 2000 13: 229 234.
15. Andega S et al. Comparison of the effect of fatty alcohols on the permeation of melatonin between porcine and human skin. J Control Release 2001 77: 17 25.
16. Jacques P et al. Optimization of biosurfactant lipopeptide production from Bacillus subtilis S499 by Plackett-Burman design. Appl Biochem Biotechnol 1999 77-79: 223 233.
17. Razafindralambo H et al. Purification of antifungal lipopeptides by reversed-phase high-performance liquid chromatography. J Chromatogr 1993 639: 81 85.
18. Law S et al. Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. Arch Oral Biol 1995 40: 1085 1091.
19. Volpato NM et al. Assay of acyclovir in human skin layers by high-performance liquid chromatography. J Pharm Biomed Anal 1997 16: 515 520.
20. Vaddi HK et al. Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes. J Control Release 2002 81: 121 133.
21. Guillard EC et al. Molecular interactions of penetration enhancers within ceramides organization: a FTIR approach. Eur J Pharm Sci 2009 36: 192 199.
22. Volpato NM et al. In vitro acyclovir distribution in human skin layers after transdermal iontophoresis. J Control Release 1998 50: 291 296.
23. Ibrahim SA, Li SK. Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain. Int J Pharm 2010 383: 89 98.
24. Novotny J et al. Dimethylamino acid esters as biodegradable and reversible transdermal permeation enhancers: effects of linking chain length, chirality and polyfluorination. Pharm Res 2009 26: 811 821.
25. Bentley MV et al. Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies. Int J Pharm 1999 193: 49 55.
26. Hadgraft J et al. Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues. Int J Pharmaceutics 1996 141: 17 25.
27. Padula C et al. The influence of iontophoresis on acyclovir transport and accumulation in rabbit ear skin. Pharm Res 2005 22: 1519 1524.
28. Shukla C et al. In vivo quantification of acyclovir exposure in the dermis following iontophoresis of semisolid formulations. J Pharm Sci 2009 98: 917 925.
29. Xu Q et al. Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir. Int J Pharm 2009 369: 105 113.
30. Volpato NM et al. Iontophoresis enhances the transport of acyclovir through nude mouse skin by electrorepulsion and electroosmosis. Pharm Res 1995 12: 1623 1627.